308 related articles for article (PubMed ID: 21423208)
1. IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.
Oh JH; Cho MC; Kim JH; Lee SY; Kim HJ; Park ES; Ban JO; Kang JW; Lee DH; Shim JH; Han SB; Moon DC; Park YH; Yu DY; Kim JM; Kim SH; Yoon DY; Hong JT
Oncogene; 2011 Jul; 30(30):3345-59. PubMed ID: 21423208
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals.
Yun HM; Oh JH; Shim JH; Ban JO; Park KR; Kim JH; Lee DH; Kang JW; Park YH; Yu D; Kim Y; Han SB; Yoon DY; Hong JT
Cell Death Dis; 2013 May; 4(5):e640. PubMed ID: 23703385
[TBL] [Abstract][Full Text] [Related]
3. IL-32γ enhances TNF-α-induced cell death in colon cancer.
Park ES; Yoo JM; Yoo HS; Yoon DY; Yun YP; Hong J
Mol Carcinog; 2014 Feb; 53 Suppl 1():E23-35. PubMed ID: 23255489
[TBL] [Abstract][Full Text] [Related]
4. (E)-4-(3-(3,5-dimethoxyphenyl)allyl)-2-methoxyphenol inhibits growth of colon tumors in mice.
Zheng J; Park MH; Son DJ; Choi MG; Choi JS; Nam KT; Kim HD; Rodriguez K; Gann B; Ham YW; Han SB; Hong JT
Oncotarget; 2015 Dec; 6(39):41929-43. PubMed ID: 26474284
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of skin carcinogenesis by suppression of NF-κB dependent ITGAV and TIMP-1 expression in IL-32γ overexpressed condition.
Lee YS; Lee CH; Bae JT; Nam KT; Moon DB; Hwang OK; Choi JS; Kim TH; Jun HO; Jung YS; Hwang DY; Han SB; Yoon DY; Hong JT
J Exp Clin Cancer Res; 2018 Nov; 37(1):293. PubMed ID: 30486830
[TBL] [Abstract][Full Text] [Related]
6. IL-32 gamma reduces lung tumor development through upregulation of TIMP-3 overexpression and hypomethylation.
Yun J; Park MH; Son DJ; Nam KT; Moon DB; Ju JH; Hwang OK; Choi JS; Kim TH; Jung YS; Hwang DY; Han SB; Yoon DY; Hong JT
Cell Death Dis; 2018 Feb; 9(3):306. PubMed ID: 29467412
[TBL] [Abstract][Full Text] [Related]
7. Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.
De Simone V; Franzè E; Ronchetti G; Colantoni A; Fantini MC; Di Fusco D; Sica GS; Sileri P; MacDonald TT; Pallone F; Monteleone G; Stolfi C
Oncogene; 2015 Jul; 34(27):3493-503. PubMed ID: 25174402
[TBL] [Abstract][Full Text] [Related]
8. IL-32γ suppresses lung cancer stem cell growth via inhibition of ITGAV-mediated STAT5 pathway.
Lee YS; Kim KC; Mongre RK; Kim JY; Kim YR; Choi DY; Song S; Yun J; Han SB; Yoon DY; Hong JT
Cell Death Dis; 2019 Jul; 10(7):506. PubMed ID: 31263095
[TBL] [Abstract][Full Text] [Related]
9. 4-O-methylhonokiol inhibits colon tumor growth via p21-mediated suppression of NF-κB activity.
Oh JH; Ban JO; Cho MC; Jo M; Jung JK; Ahn B; Yoon DY; Han SB; Hong JT
J Nutr Biochem; 2012 Jul; 23(7):706-15. PubMed ID: 21820300
[TBL] [Abstract][Full Text] [Related]
10. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-32γ attenuates ethanol-induced liver injury by the inhibition of cytochrome P450 2E1 expression and inflammatory responses.
Lee DH; Kim DH; Hwang CJ; Song S; Han SB; Kim Y; Yoo HS; Jung YS; Kim SH; Yoon DY; Hong JT
Clin Sci (Lond); 2015 May; 128(10):695-706. PubMed ID: 25583360
[TBL] [Abstract][Full Text] [Related]
12. Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice.
Li TW; Yang H; Peng H; Xia M; Mato JM; Lu SC
Carcinogenesis; 2012 Feb; 33(2):427-35. PubMed ID: 22159228
[TBL] [Abstract][Full Text] [Related]
13. The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells.
Ziesché E; Bachmann M; Kleinert H; Pfeilschifter J; Mühl H
J Biol Chem; 2007 Jun; 282(22):16006-15. PubMed ID: 17438334
[TBL] [Abstract][Full Text] [Related]
14. IL-32γ suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B.
Lee YS; Han SB; Ham HJ; Park JH; Lee JS; Hwang DY; Jung YS; Yoon DY; Hong JT
J Allergy Clin Immunol; 2020 Jul; 146(1):156-168. PubMed ID: 31931018
[TBL] [Abstract][Full Text] [Related]
15. Growth inhibitory effects of obovatol through induction of apoptotic cell death in prostate and colon cancer by blocking of NF-kappaB.
Lee SY; Yuk DY; Song HS; Yoon DY; Jung JK; Moon DC; Lee BS; Hong JT
Eur J Pharmacol; 2008 Mar; 582(1-3):17-25. PubMed ID: 18241858
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of inhibitory effect of nuclear factor-kappaB activity by small interfering RNA on pro-tumor characteristics of M2-like macrophages.
Kono Y; Kawakami S; Higuchi Y; Yamashita F; Hashida M
Biol Pharm Bull; 2014; 37(1):137-44. PubMed ID: 24141263
[TBL] [Abstract][Full Text] [Related]
17. Chrysoeriol ameliorates TPA-induced acute skin inflammation in mice and inhibits NF-κB and STAT3 pathways.
Wu JY; Chen YJ; Bai L; Liu YX; Fu XQ; Zhu PL; Li JK; Chou JY; Yin CL; Wang YP; Bai JX; Wu Y; Wu ZZ; Yu ZL
Phytomedicine; 2020 Mar; 68():153173. PubMed ID: 31999977
[TBL] [Abstract][Full Text] [Related]
18. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells.
Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ
Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894
[TBL] [Abstract][Full Text] [Related]
19. Anti-cancer effect of bee venom on colon cancer cell growth by activation of death receptors and inhibition of nuclear factor kappa B.
Zheng J; Lee HL; Ham YW; Song HS; Song MJ; Hong JT
Oncotarget; 2015 Dec; 6(42):44437-51. PubMed ID: 26561202
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of NF-kappaB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel.
Kim SM; Lee SY; Yuk DY; Moon DC; Choi SS; Kim Y; Han SB; Oh KW; Hong JT
Arch Pharm Res; 2009 May; 32(5):755-65. PubMed ID: 19471891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
